This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
CDC. https://www.cdc.gov/vhf/ebola/history/chronology.html (accessed on 16 March 2023).
Cenciarelli, O. et al. Int. J. Microbiol. https://doi.org/10.1155/2015/769121 (2015).
Wang, Y. et al. Human Vaccines Immunother. 13, 153–168 (2017).
Larivière, Y. et al. BMJ Open 11, e046835 (2021).
Mulangu, S. et al. New Engl. J. Med. 381, 2293–2303 (2019).
WHO. https://go.nature.com/3MJxnnY (accessed 16 March 2023).
WHO. https://go.nature.com/3WHbuui (accessed 16 March 2023).
WHO. https://www.who.int/campaigns/vaccine-equity (accessed 16 March 2023).
Sidik, S. M. Nature 606, 638–639 (2022).
WHO. https://go.nature.com/3MJfW7h (2022).
H.K.B., R.K., H.M., D.A. and J.R.A. are employees of the Ministry of Health, Government of Uganda. F.O. is an employee of the Africa Center for Global Health and Social Transformation, Uganda. Y.T.W. is an employee of the World Health Organization. All other authors declare no competing interests.
About this article
Cite this article
Kyobe Bosa, H., Njenga, M.K., Wayengera, M. et al. Leveraging the structures of the COVID-19 pandemic response for successful control of Ebola in Uganda. Nat Med 29, 1892–1893 (2023). https://doi.org/10.1038/s41591-023-02395-4